Want to see SMTI full AI Analyst Report?
Sanara MedTech (SMTI) Ratios
Sanara MedTech Ratios
SMTI's free cash flow for Q2 2026 was $2.03M. For the 2026 fiscal year, SMTI's free cash flow was decreased by $-5.28K and operating cash flow was $2.04M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.80 | 2.18 | 1.38 | 1.61 | 4.09 |
| Quick Ratio | 1.59 | 2.00 | 1.04 | 1.33 | 3.75 |
| Cash Ratio | 0.89 | 1.04 | 0.37 | 0.70 | 3.10 |
| Solvency Ratio | -0.13 | -0.10 | -0.02 | -0.29 | -1.15 |
| Operating Cash Flow Ratio | 0.36 | -0.00 | -0.24 | -0.43 | -0.80 |
| Short-Term Operating Cash Flow Coverage | 19.21 | 0.00 | -5.59 | 0.00 | 0.00 |
| Net Current Asset Value | $ -33.47M | $ -15.87M | $ -10.28M | $ 1.30M | $ 18.36M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.66 | 0.37 | 0.16 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 8.13 | 0.82 | 0.26 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.89 | 0.45 | 0.21 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.89 | 0.44 | 0.17 | 0.00 | 0.00 |
| Financial Leverage Ratio | 12.30 | 2.24 | 1.65 | 1.46 | 1.19 |
| Debt Service Coverage Ratio | 4.91 | -0.59 | -0.27 | -20.09 | -10156.33 |
| Interest Coverage Ratio | 1.35 | -2.15 | -8.86 | -43.96 | -10374.34 |
| Debt to Market Cap | 0.23 | 0.11 | 0.03 | 0.00 | 0.00 |
| Interest Debt Per Share | 6.37 | 4.17 | 1.48 | 0.14 | 0.06 |
| Net Debt to EBITDA | 0.91 | -8.82 | -22.98 | 0.70 | 2.52 |
| Profitability Margins | |||||
| Gross Profit Margin | 90.13% | 90.61% | 87.92% | 86.12% | 90.43% |
| EBIT Margin | 6.17% | -7.83% | -6.10% | -30.40% | -33.11% |
| EBITDA Margin | 33.87% | -2.15% | -0.44% | -25.23% | -29.91% |
| Operating Profit Margin | 8.87% | -7.75% | -6.49% | -27.30% | -30.55% |
| Pretax Profit Margin | -0.38% | -11.44% | -6.83% | -30.40% | -33.11% |
| Net Profit Margin | -36.43% | -11.15% | -6.62% | -17.31% | -32.81% |
| Continuous Operations Profit Margin | -0.38% | -11.44% | -6.83% | -17.65% | -33.11% |
| Net Income Per EBT | 9554.90% | 97.50% | 96.92% | 56.95% | 99.10% |
| EBT Per EBIT | -4.30% | 147.60% | 105.33% | 111.34% | 108.37% |
| Return on Assets (ROA) | -51.50% | -10.97% | -5.83% | -13.00% | -21.77% |
| Return on Equity (ROE) | -633.46% | -24.53% | -9.60% | -18.98% | -25.85% |
| Return on Capital Employed (ROCE) | 16.84% | -9.22% | -7.01% | -25.95% | -24.28% |
| Return on Invested Capital (ROIC) | 16.73% | -9.18% | -6.91% | -14.97% | -24.12% |
| Return on Tangible Assets | -74.09% | -22.23% | -16.98% | -30.62% | -25.02% |
| Earnings Yield | -18.66% | -3.43% | -1.26% | -2.21% | -3.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.59 | 6.40 | 7.62 | 6.55 | 8.07 |
| Payables Turnover | 4.35 | 5.43 | 3.92 | 4.46 | 3.89 |
| Inventory Turnover | 2.58 | 2.96 | 1.66 | 1.79 | 1.13 |
| Fixed Asset Turnover | 40.72 | 46.10 | 19.98 | 20.62 | 11.82 |
| Asset Turnover | 1.41 | 0.98 | 0.88 | 0.75 | 0.66 |
| Working Capital Turnover Ratio | 6.26 | 7.45 | 9.96 | 3.47 | 2.47 |
| Cash Conversion Cycle | 100.18 | 113.26 | 174.15 | 177.55 | 274.86 |
| Days of Sales Outstanding | 42.47 | 57.07 | 47.92 | 55.76 | 45.20 |
| Days of Inventory Outstanding | 141.54 | 123.45 | 219.28 | 203.65 | 323.46 |
| Days of Payables Outstanding | 83.83 | 67.25 | 93.05 | 81.87 | 93.80 |
| Operating Cycle | 184.01 | 180.51 | 267.20 | 259.41 | 368.66 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.79 | -0.00 | -0.39 | -0.70 | -0.66 |
| Free Cash Flow Per Share | 0.25 | -0.03 | -0.42 | -0.80 | -0.76 |
| Dividend Paid and CapEx Coverage Ratio | 1.47 | -0.10 | -12.24 | -7.44 | -6.42 |
| Capital Expenditure Coverage Ratio | 1.47 | -0.10 | -12.24 | -7.44 | -6.42 |
| Operating Cash Flow Coverage Ratio | 0.14 | -0.00 | -0.28 | -6.78 | -11.32 |
| Operating Cash Flow to Sales Ratio | 0.07 | -0.00 | -0.05 | -0.12 | -0.20 |
| Free Cash Flow Yield | 1.07% | -0.09% | -1.03% | -1.75% | -2.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.36 | -29.12 | -79.07 | -45.32 | -27.39 |
| Price-to-Sales (P/S) Ratio | 1.95 | 3.25 | 5.24 | 7.85 | 8.99 |
| Price-to-Book (P/B) Ratio | 33.96 | 7.15 | 7.59 | 8.60 | 7.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 93.17 | -1112.98 | -96.92 | -57.09 | -38.98 |
| Price-to-Operating Cash Flow Ratio | 29.67 | -11843.10 | -104.84 | -64.76 | -45.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | -0.24 | 1.65 | 6.12 | -0.65 |
| Enterprise Value Multiple | 6.67 | -160.24 | -1199.98 | -30.40 | -27.52 |
| Enterprise Value | 232.96M | 298.08M | 346.91M | 351.62M | 198.72M |
| EV to EBITDA | 6.67 | -160.24 | -1199.98 | -30.40 | -27.52 |
| EV to Sales | 2.26 | 3.44 | 5.34 | 7.67 | 8.23 |
| EV to Free Cash Flow | 107.80 | -1177.80 | -98.81 | -55.80 | -35.71 |
| EV to Operating Cash Flow | 34.33 | -12532.92 | -106.89 | -63.30 | -41.27 |
| Tangible Book Value Per Share | -1.89 | -0.67 | -0.48 | 0.84 | 3.46 |
| Shareholders’ Equity Per Share | 0.69 | 4.64 | 5.42 | 5.29 | 4.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.42 | 0.00 |
| Revenue Per Share | 11.96 | 10.22 | 7.85 | 5.80 | 3.29 |
| Net Income Per Share | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
| Tax Burden | 95.55 | 0.98 | 0.97 | 0.57 | 0.99 |
| Interest Burden | -0.06 | 1.46 | 1.12 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.05 | 0.07 | 0.06 | 0.07 | 0.02 |
| SG&A to Revenue | 0.76 | 0.88 | 0.00 | 1.00 | 1.16 |
| Stock-Based Compensation to Revenue | 0.01 | 0.05 | 0.05 | 0.06 | 0.11 |
| Income Quality | -0.25 | 0.00 | 0.73 | 0.69 | 0.60 |
Currency in USD
